New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Fractyl Health, Inc. (GUTS) vs Neuphoria Therapeutics Inc. (NEUP)
- Fractyl Health, Inc. GUTS 0.82 −14.58%
- Neuphoria Therapeutics Inc. NEUP 2.35 +1.29%
Fractyl Health, Inc. and Neuphoria Therapeutics Inc. are both Biotechnology companies. Fractyl Health, Inc. and Neuphoria Therapeutics Inc. are of similar size ($12.7M and $12.6M). Across the 11 metrics below, Neuphoria Therapeutics Inc. leads on 6 and Fractyl Health, Inc. on 5.
Valuation
Profitability
| Metric | GUTS | NEUP | Biotechnology median |
|---|---|---|---|
| Gross margin | 46.24% | — | 70.18% |
| Operating margin | (100,570.97%) | — | 0.00% |
| Net margin | (75,732.26%) | — | 0.00% |
| Free cash flow margin | (72,350.54%) | — | 0.00% |
| Return on equity | 905.17% | (27.63%) | (51.58%) |
| Return on assets | (82.35%) | (18.26%) | (45.91%) |
| Return on invested capital | 0.00% | (186.04%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack